Proof of concept study of combined allergen immunotherapy and antibiotics for the treatment of chronic atopic dermatitis
过敏原免疫疗法和抗生素联合治疗慢性特应性皮炎的概念验证研究
基本信息
- 批准号:G0701693/1
- 负责人:
- 金额:$ 39.4万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2009
- 资助国家:英国
- 起止时间:2009 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Atopic dermatitis (eczema) affects up to 20% of the UK population and is strongly associated with asthma and hayfever. We have shown that a common skin infection, Staphylococcus aureus, can dramatically alter how the body reacts to harmless environmental proteins or allergens. Therefore individuals are more likely to react to an allergen, such as house dust mite, if they encounter it at the same time as staphylococcal infection. Our findings potentially provide a new mechanism for atopic dermatitis and also for atopic and other allergic diseases, including asthma, hayfever and peanut allergy. We will investigate whether by combining anti-bacterial treatment with allergen desensitisation it is possible to improve symptoms in adult individuals with severe atopic dermatitis. We will also take blood samples from study subjects to examine changes in the immune response during treatment. This will give us important insights into how the disease occurs and how we can improve on our results in future clinical trials.We will present our findings at scientific meetings and through publications, but will also liaise with the public and press whenever appropriate. Dr Graham Ogg has been involved in the presentation of science to the public, for example at the Royal Society Summer Science Exhibition and through the national Public Understanding of Science events and promotes the importance of public engagement in science.
特应性皮炎(湿疹)影响多达 20% 的英国人口,并且与哮喘和花粉症密切相关。我们已经证明,一种常见的皮肤感染金黄色葡萄球菌可以极大地改变身体对无害的环境蛋白质或过敏原的反应。因此,如果个人在葡萄球菌感染的同时遇到过敏原,例如屋尘螨,则更有可能对其产生反应。我们的研究结果可能为特应性皮炎以及特应性和其他过敏性疾病(包括哮喘、花粉热和花生过敏)提供新机制。我们将研究通过将抗菌治疗与过敏原脱敏相结合是否可以改善患有严重特应性皮炎的成年个体的症状。我们还将从研究对象身上采集血液样本,以检查治疗期间免疫反应的变化。这将为我们提供有关疾病如何发生以及如何在未来临床试验中改进结果的重要见解。我们将在科学会议和出版物上展示我们的研究结果,但也会在适当的时候与公众和媒体联络。格雷厄姆·奥格博士一直致力于向公众展示科学,例如在皇家学会夏季科学展览上以及通过全国公众理解科学活动,并宣传公众参与科学的重要性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Graham Ogg其他文献
Viral loads in primary varicella zoster virus infection
- DOI:
10.1016/j.jinf.2008.01.037 - 发表时间:
2008-04-01 - 期刊:
- 影响因子:
- 作者:
Gathsaurie Malavige;Lousie Jones;Antony Black;Ananda Wijewickrama;Suranjith Seneviratne;Satheeka Kamaladasa;Graham Ogg - 通讯作者:
Graham Ogg
Can AlphaFold’s breakthrough in protein structure help decode the fundamental principles of adaptive cellular immunity?
阿尔法折叠在蛋白质结构方面的突破能否帮助解码适应性细胞免疫的基本原理?
- DOI:
10.1038/s41592-024-02240-7 - 发表时间:
2024-04-23 - 期刊:
- 影响因子:32.100
- 作者:
Benjamin McMaster;Christopher Thorpe;Graham Ogg;Charlotte M. Deane;Hashem Koohy - 通讯作者:
Hashem Koohy
Identification and characterisation of DerP1-specific CD8+T cells in the peripheral blood of atopic individuals
- DOI:
10.1016/s0091-6749(02)82269-2 - 发表时间:
2002-01-01 - 期刊:
- 影响因子:
- 作者:
Suranjith Seneviratne;Louis Jones;Abigail King;Antony Black;Shiela Powell;Andrew McMichael;Graham Ogg - 通讯作者:
Graham Ogg
Antibody-targeted MHC complex–directed expansion of HIV-1– and KSHV-specific CD8<sup>+</sup> lymphocytes: a new approach to therapeutic vaccination
- DOI:
10.1182/blood-2003-09-3023 - 发表时间:
2004-03-01 - 期刊:
- 影响因子:
- 作者:
Justin Stebbing;Brian Gazzard;Steve Patterson;Mark Bower;Dhayaneethie Perumal;Mark Nelson;Andrew McMichael;Graham Ogg;Agamemnon Epenetos;Frances Gotch;Philip Savage - 通讯作者:
Philip Savage
Phenotypic analysis of human cd4+ t cells specific for ie63 protein of vzv
- DOI:
10.1016/j.jinf.2008.01.020 - 发表时间:
2008-04-01 - 期刊:
- 影响因子:
- 作者:
Louise Jones;Antony Black;Gathsaurie Malavige;Graham Ogg - 通讯作者:
Graham Ogg
Graham Ogg的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Graham Ogg', 18)}}的其他基金
SARS-Cov2 equipment purchases for HIU to support their COVID-19 activities
为 HIU 购买 SARS-Cov2 设备以支持其 COVID-19 活动
- 批准号:
MC_PC_20002 - 财政年份:2020
- 资助金额:
$ 39.4万 - 项目类别:
Intramural
MICA: Targeting of CD1a for treatment of inflammatory skin disease
MICA:靶向 CD1a 治疗炎症性皮肤病
- 批准号:
MC_EX_MR/R022550/1 - 财政年份:2018
- 资助金额:
$ 39.4万 - 项目类别:
Research Grant
相似海外基金
Repurposing Sodium Cromoglycate For Lymphangioleiomyomatosis (LAM): An Open Label, Proof Of Concept And Feasibility Study
重新利用色甘酸钠治疗淋巴管平滑肌瘤病 (LAM):开放标签、概念验证和可行性研究
- 批准号:
MR/Y008618/1 - 财政年份:2024
- 资助金额:
$ 39.4万 - 项目类别:
Research Grant
A Phase I Proof-of-Concept Study of CBL0137 Combined with Ipilimumab and Nivolumab Therapy in Locally Advanced or Metastatic Melanoma
CBL0137 联合 Ipilimumab 和 Nivolumab 治疗局部晚期或转移性黑色素瘤的 I 期概念验证研究
- 批准号:
10722873 - 财政年份:2023
- 资助金额:
$ 39.4万 - 项目类别:
Characterizing the impact of hysterectomy on female physiology: A proof-of-concept cohort study in pelvic organ prolapse patients
描述子宫切除术对女性生理的影响:盆腔器官脱垂患者的概念验证队列研究
- 批准号:
486839 - 财政年份:2023
- 资助金额:
$ 39.4万 - 项目类别:
Operating Grants
Metformin as a novel, mechanistic treatment of fibromyalgia; a proof of concept RCT
二甲双胍作为纤维肌痛的新型机械治疗方法;
- 批准号:
10655834 - 财政年份:2023
- 资助金额:
$ 39.4万 - 项目类别:
Proof of concept study of a highly novel food fortification to boost exercise performance in younger and older adults
一种高度新颖的食品强化剂的概念验证研究,可提高年轻人和老年人的运动表现
- 批准号:
10073883 - 财政年份:2023
- 资助金额:
$ 39.4万 - 项目类别:
Collaborative R&D
Transformer-empowered medical AI imaging: a proof-of-concept study
变压器支持的医疗人工智能成像:概念验证研究
- 批准号:
22K15853 - 财政年份:2022
- 资助金额:
$ 39.4万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Proof of Concept Trial of Cannabis Derivatives in Neuropathic Pain.
大麻衍生物治疗神经性疼痛的概念验证试验。
- 批准号:
10426260 - 财政年份:2022
- 资助金额:
$ 39.4万 - 项目类别:
Small molecule inhibitors of hyperphosphorylated tau aggregation in Alzheimer's disease: lead optimization, and proof of concept in a rodent model
阿尔茨海默病中过度磷酸化 tau 蛋白聚集的小分子抑制剂:先导化合物优化和啮齿动物模型中的概念验证
- 批准号:
10621755 - 财政年份:2022
- 资助金额:
$ 39.4万 - 项目类别:
Proof of Concept Trial of Cannabis Derivatives in Neuropathic Pain.
大麻衍生物治疗神经性疼痛的概念验证试验。
- 批准号:
10284669 - 财政年份:2022
- 资助金额:
$ 39.4万 - 项目类别:
Small molecule inhibitors of hyperphosphorylated tau aggregation in Alzheimer's disease: lead optimization, and proof of concept in a rodent model
阿尔茨海默病中过度磷酸化 tau 蛋白聚集的小分子抑制剂:先导化合物优化和啮齿动物模型中的概念验证
- 批准号:
10371380 - 财政年份:2022
- 资助金额:
$ 39.4万 - 项目类别: